Coronavirus live news: Delta ‘crippling’ Alaska’s healthcare system; South Korea urges testing amid holiday surge fears
- England’s Covid travel rules spark outrage around the world
- FDA approves Pfizer booster shots for Americans ages 65 and older
- New Zealanders could get Covid jab with fast-food fix
- See all our coronavirus coverage
UK business minister Paul Scully has claimed the energy price cap is “keeping prices down” and that the government is in talks with regulator Ofgem.
He told Sky News that the government has also had conversations about how much a price cap may have to go up.
South Korean authorities warned people returning from a holiday to get tested even for the mildest Covid type symptoms, especially before clocking in for work amid a new surge in coronavirus cases in and around the capital, Reuters reports.
The country, which has been grappling with a fourth wave of infections since early July, will on Friday roll back the allowance gatherings during the Chuseok holiday week to two people after 6 p.m. in the greater Seoul area.
Seoul saw 1,400 daily confirmed cases on average last week, up 11% from a record high of 1,268 the prior week, Vice Health Minister Kang Do-tae said on Wednesday.
Kang urged those returning from the three-day holiday, which started on Monday, to get tested to prevent transmission.
South Korea’s popular tourist island of Jeju saw an average of more than 41,000 visitors a day during the holiday, up from about 32,000 in the same period last year, the Jeju Tourism Association told Reuters. More than 258,000 people have visited the island in six days.
Despite the high daily case numbers, the mortality rate and severe cases have remained relatively low and steady at 0.83% and 312 respectively as of Wednesday, Korea Disease Control and Prevention Agency (KDCA) data showed.
The KDCA reported 1,716 new Covid cases on Wednesday, raising the total to 292,699 infections, with 2,427 deaths.
South Korea struggled to get vaccine supplies initially, but has supercharged its campaign in recent months, administering 71.2% of the 52 million population with at least one dose through Wednesday and fully inoculated 43.2%.